Search results (23 results)
-
Hydroxychloroquine Maculopathy
Jul 23 2023 by Ahmad B. Tarabishy, MD
62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.
Photographer: Dr. Angela Rico
Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy
-
Hydroxychloroquine Maculopathy
Jul 23 2023 by Ahmad B. Tarabishy, MD
62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.
Photographer: Dr. Angela Rico
Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy
-
Hydroxychloroquine Maculopathy
Jul 23 2023 by Ahmad B. Tarabishy, MD
62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.
Photographer: Dr. Angela Rico
Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy
-
Hydroxychloroquine Maculopathy
Jul 23 2023 by Ahmad B. Tarabishy, MD
62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.
Photographer: Dr. Angela Rico
Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy
-
Hydroxychloroquine Maculopathy
Jul 23 2023 by Ahmad B. Tarabishy, MD
62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.
Photographer: Dr. Angela Rico
Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy
-
Hydroxychloroquine Maculopathy
Jul 23 2023 by Ahmad B. Tarabishy, MD
62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.
Photographer: Dr. Angela Rico
Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy
-
Hydroxychloroquine Maculopathy
Jul 23 2023 by Ahmad B. Tarabishy, MD
62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.
Photographer: Dr. Angela Rico
Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy
-
Hydroxychloroquine Maculopathy
Jul 23 2023 by Ahmad B. Tarabishy, MD
62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.
Photographer: Dr. Angela Rico
Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy
-
Plaquenil Toxicity
Feb 25 2021 by Niloofar Piri, MD
Bilateral fundus autofluorescence of a patient with hydroxycholoroquine (plaquenil) toxicity demonstrating classic bull's eye pattern.
Condition/keywords: bull's eye maculopathy, hydroxychloroquine toxicity, plaquenil toxicity
-
Plaquenil Toxicity
Mar 26 2019 by Gary R. Cook, MD, FACS
61-year-old white female with Bull's-eye maculopathy OD secondary to plaquenil toxicity; VA= 20/40.
Imaging device: Topcon VT-50
Condition/keywords: bull's eye atrophy, bull's eye maculopathy, hydroxychloroquine toxicity, plaquenil toxicity
-
Plaquenil Toxicity
Mar 26 2019 by Gary R. Cook, MD, FACS
3-minute mid-venous phase FA frame from a 61-year-old white female with a Bull's-eye maculopathy OD secondary to Plaquenil toxicity; VA=20/40.
Imaging device: Topcon VT-50
Condition/keywords: bull's eye atrophy, bull's eye maculopathy, fluorescein angiogram (FA), hydroxychloroquine toxicity, plaquenil toxicity
-
Plaquenil Toxicity
Mar 26 2019 by Gary R. Cook, MD, FACS
61-year-old white female with a Bull's-eye maculopathy OS secondary to Plaquenil toxicity; VA= 20/30.
Imaging device: Topcon VT-50
Condition/keywords: bull's eye atrophy, bull's eye maculopathy, hydroxychloroquine toxicity, plaquenil toxicity
-
Plaquenil Toxicity
Mar 26 2019 by Gary R. Cook, MD, FACS
Mid-venous phase FA frame from a 61-year-old white female with a Bull's-eye maculopathy OS secondary to Plaquenil toxicity; VA= 20/30.
Imaging device: Topcon VT-50
Condition/keywords: bull's eye atrophy, bull's eye maculopathy, fluorescein angiogram (FA), hydroxychloroquine toxicity, plaquenil toxicity
-
Plaquenil Toxicity
Apr 30 2013 by Theodore Leng, MD, MS, FASRS
SD-OCT scan from a 44-year-old woman with bilateral plaquenil toxicity. There is damage visible in the outer retina in a perifoveal distribution.
Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity
-
Plaquenil Toxicity
Apr 30 2013 by Theodore Leng, MD, MS, FASRS
SD-OCT scan from a 44-year-old woman with bilateral plaquenil toxicity. There is damage visible in the outer retina in a perifoveal distribution.
Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity
-
Plaquenil Toxicity
Apr 30 2013 by Theodore Leng, MD, MS, FASRS
Color fundus photograph from a 44-year-old woman with bilateral plaquenil toxicity. A mild bulls-eye maculopathy is present.
Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity
-
Plaquenil Toxicity
Apr 30 2013 by Theodore Leng, MD, MS, FASRS
Fundus autofluorescence from a 44-year-old woman with bilateral plaquenil toxicity. There is an area of hyperautofluorescence that corresponds to areas of outer retinal damage.
Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity
-
Plaquenil Toxicity
Apr 30 2013 by Theodore Leng, MD, MS, FASRS
Right eye 10-2 HVF from a 44-year-old woman with bilateral plaquenil toxicity. A ring scotoma is present.
Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity
-
Plaquenil Toxicity
Apr 30 2013 by Theodore Leng, MD, MS, FASRS
Color fundus photograph from a 44-year-old woman with bilateral plaquenil toxicity. A mild bulls-eye maculopathy is present.
Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity
-
Plaquenil Toxicity
Apr 30 2013 by Theodore Leng, MD, MS, FASRS
Fundus autofluorescence from a 44-year-old woman with bilateral plaquenil toxicity. There is an area of hyperautofluorescence that corresponds to areas of outer retinal damage.
Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity
-
Plaquenil Toxicity
Apr 30 2013 by Theodore Leng, MD, MS, FASRS
Left Eye 10-2 HVF from a 44-year-old woman with bilateral plaquenil toxicity. A ring scotoma is present.
Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity
-
Plaquenil Toxicity: "Flying Saucer"
Feb 25 2021 by Niloofar Piri, MD
SD- OCT of the same patient with hydroxychloroquine (Plaquenil) toxicity, demonstrating classic "Flying Saucer" pattern secondary to parafoveal RPE atrophy, and outer retinal layer disruption including EZ loss, and outer nuclear layer loss.
Condition/keywords: bull's eye maculopathy, hydroxychloroquine toxicity, plaquenil toxicity
-
Plaquenil-toxicity
Mar 31 2023 by Niloofar Piri, MD
Fundus autofluorescence image of the right eye in a highly myopic Caucasian patient who was screened for plaquenil toxicity elsewhere for 15 years. Medicine was stopped 3 years ago. She presented to us with deteriorationg central vision and scotoma for the past 3 years. FAF demonstrtaes classic symmetric bull's eye pattern of hypoautofluorescence in parafoveal area both eyes with some extension to the arcades, which is the result of severe plaquenil toxicity. Notice the hyperAF area surrounding the bull'e eye which is demonstarting stressed RPE cells filled with Lipofuscin. This area will likely turn to a larger hypoAF later. It is critical to diagnose it early to prevent the ongoing damage and loss of RPE and photoreceptors from the long term deposited medicine in RPE cells.
Photographer: Sean Kelso, Saint Lousi University
Condition/keywords: bull's eye atrophy, bull's eye maculopathy, hydroxychloroquine toxicity, plaquenil toxicity